Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 7, 2000 - Issue 3
45
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Transformation of beta-amyloid (Aβ) (1-42) tyrosine to L-Dopa as the result of in vitro hydroxyl radical attack

, , , &
Pages 189-193 | Received 29 Jul 1999, Accepted 17 Mar 2000, Published online: 06 Jul 2009
 

Abstract

A form of beta-amyloid peptide Aβ ending at amino acid 42 (Aβ42) is the major component of senile amyloid plaques in Alzheimer's Disease (AD). The Aβ-peptide earliest modifications are extremely important since they constitute the key events in the progression towards further changes finally leading to fibril formation and to Aβ deposits which constitute the core pathological change in AD. Chemical and conformational early modifications of the beta-amyloid peptide are critical steps in AD pathogenesis and have been widely investigated. We now show that a Fenton-type OH-generating system is capable of generating L-Dopa (3, 4-dihydroxyphenylalanine) in the tyrosine residue of Aβ-peptide via aromatic ring hydroxylation, as the result of hydroxyl radical attack on proteins. Since L-Dopa is not a constituent of mammalian proteins and peptides, the formation of L-Dopa in Aβ in vitro constitutes a possible important modification caused by hydroxyl radical attack These results lay the groundwork for further studies on modification and damage associated with the degenerative disorder in AD where oxidative stress and inflammation are known to occur.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.